
Organization · Venture Capital
ILUM Tec GmbH
ILUM Tec GmbH is a Vienna-based investment company focused on high-tech startups in Central Europe, particularly in life sciences and regenerative medicine. It provides seed and follow-on financing while aiming for strong minority stakes in its portfolio companies.
Overview
What ILUM Tec GmbH does
What ILUM Tec GmbH is
ILUM Tec GmbH is a Vienna-based investment company focused on high-tech startups in Central Europe, particularly in life sciences and regenerative medicine. It provides seed and follow-on financing while aiming for strong minority stakes in its portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find ILUM Tec GmbH elsewhere
Open the official website or a supported primary organization account.
Capability profile
ILUM Tec GmbH as a funder
Investment thesis
ILUM Tec GmbH invests in attractive Central European life-science and high-technology companies, especially regenerative medicine, targeting young companies and startups with seed and follow-up financing while seeking strong minority stakes.
Focus narrative
ILUM Tec primarily invests in the life sciences and high technology sectors, with a special emphasis on regenerative medicine. The organization supports companies through various stages of growth, from seed funding to potential IPOs, enhancing the value of its investments through strategic growth and exit opportunities.
Value beyond capital
ILUM Tec adds value to its portfolio companies through know-how, subsidies and public funding, patents/contracts, professional management teams, targeted networking, administrative services, and synergies among its holdings.
Focus and fit
- Stages
- Seed · Friends and Family · Series A · Series B · Growth Equity · Pre-IPO
- Regions
- Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Ascense Medical: Develops vascular and endovascular prostheses using elastic material designed to mimic healthy aortic tissue. AURIMOD: Develops VIVO, a pain-treatment product based on auricular vagus nerve stimulation. ImageBiopsy Lab: AI platform helping physicians turn X-rays into musculoskeletal diagnostic findings. MorphoMed: Develops regenerative grafts from medical silk and stem-cell concentrate processes for ligament and tendon regeneration. NanoVoxel: Full-service provider for high-precision micro-components using 3D printing and micro-manufacturing. Regenera: Develops stem-cell therapy for acute spinal cord injuries. UpNano: High-resolution 3D printing company commercializing two-photon polymerization systems and services.
Connected ecosystem
Continue from ILUM Tec GmbH
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about ILUM Tec GmbH
Upseed classifies ILUM Tec GmbH under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.